Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Bayer : New scholarships worth EUR 417,000 awarded by Bayer Foundation to promote international talents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/21/2017 | 10:10am CEST

Leverkusen, September 21, 2017- With approximately EUR 417,000, the Bayer Science & Education Foundation is providing a record amount for 65 talented young people who wish to realize international study and vocational training projects. The new scholarship recipients are students of the natural sciences, agriculture and medicine, as well those training to become science teachers or young people from skilled non-academic professions. 'We need dedicated and creative young scientists if we are to successfully shape the future. That's why with the Bayer Fellowship Program we are helping talented young people to participate in special projects abroad,' says Kemal Malik, Bayer Management Board member responsible for Innovation.

Today's 'Bayer Fellowship program' follows the tradition of the first company scholarships initiated back in 1923 by Dr. Carl Duisberg, at that time Managing Director of the Bayer Group. Duisberg is regarded as a pioneer in the intensive cooperation between industry and universities, as well as in corporate social responsibility. Explains Dr. Carl-Heinz Duisberg, member of the Scientific Committee of the Bayer Fellowship Program and youngest grandchild of the program's founder: 'My grandfather wanted to provide the best development opportunities for young talents because he saw this as a means of ensuring long-term benefits for society. He is also quoted as saying 'We must spend every spare penny on science - it is the best investment we can make.''

All scholarships underline the mission of the Bayer foundation to work with young people and the next generation of scientists and opinion-leaders and to strengthen interest in the major challenges facing our society, such as health and agriculture.

Alongside the Otto Bayer, Jozef Schell and Carl Duisberg scholarships, the Bayer Fellowship Program also includes the Kurt Hansen and Hermann Strenger scholarships. For the third time, the Bayer Science & Education Foundation offers an additional special budget for 'Talents for Africa'. The scholarships are targeted at students and vocational trainees in natural science and medical disciplines who would like to realize a particular foreign study project and require financial support for this. In addition to Germany-based applicants who would like to study abroad, the foundation supports scholarship recipients from outside of Germany who wish to realize a comparable project in Germany.

Academic disciplines receiving support this year include the life sciences, chemistry, agriculture as well as human and veterinary medicine, with a total of 56 scholarships being awarded. Three Kurt Hansen scholarship recipients are also receiving assistance for teacher training in the natural sciences. The scholarships in the academic sector are being supplemented by Hermann Strenger scholarships to support young people looking to gain initial work experience abroad as part of a non-academic training program. This year, six young people from Germany are being supported who are planning a period abroad as part of their commercial, technical or health profession training.

Thanks to the Bayer scholarships, 47 new fellows from Germany will start their projects in 18 different countries: Argentina, Australia, Brazil, Chile, Ethiopia, France, Gabon, Israel, Mexico, Nicaragua, Russian Federation, Rwanda, Spain, Sri Lanka, Sweden, Switzerland, United Kingdom and the United States. Another 18 new scholarship winners will be able to implement their individual projects in Germany, coming from: Austria, Bangladesh, Brazil, Canada, Egypt, Finland, Italy, Mexico, Morocco, Netherlands, Nigeria, Pakistan, Russian Federation, Singapore, Syria, Tunisia, Turkey and United Kingdom.

The Bayer Science & Education Foundation thus is launching the eleventh round of its funding program, which offers targeted support for scientific exchange and international work experience for young people. It targets creative, highly motivated and socially committed young people with above-average grades.

The next round of applications starts in June 2018.

More information is available on the Internet at www.bayer-foundations.com.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Bayer AG published this content on 21 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 September 2017 08:09:01 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
10:10a BAYER : New scholarships worth EUR 417,000 awarded by Bayer Foundation to promot..
09/19 BAYER : EU agrees to extend deadline for decision on Bayer, Monsanto deal
09/19 BAYER : dismisses antitrust concerns about digital farming
09/19DJBAYER : Applies to Extend EC's Monsanto Deal Review to Early 2018
09/19 FUTURE OF FARMING DIALOG 2017 : -- Crop Science Division of Bayer well positione..
09/19DJBAYER : Stops Sale of Sterilization Implant Outside U.S.
09/18 BAYER : 506-18-1-1527-0016 - Medrad Service Contract Perform preventive maintena..
09/18 BAYER : J-- 506-18-1-1527-0016 - Medrad Service Contract Perform preventive main..
09/15 BAYER : places 9.4 percent stake in Covestro
09/15 BAYER : further reduces holding in Covestro
More news
News from SeekingAlpha
09/19 Bayer asks for more time in Monsanto deal approval
09/18 3 Reasons To Buy Bayer
09/17 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 17, 2017
09/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 81-Stock August Portfolio Update - Buying..
09/15 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 15, 2017
Financials (€)
Sales 2017 49 414 M
EBIT 2017 9 340 M
Net income 2017 5 454 M
Debt 2017 12 788 M
Yield 2017 2,54%
P/E ratio 2017 17,84
P/E ratio 2018 16,12
EV / Sales 2017 7,61x
EV / Sales 2018 7,25x
Capitalization 363 B
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 118 €
Spread / Average Target 7,3%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER11.47%431 753
JOHNSON & JOHNSON16.70%362 930
NOVARTIS11.20%225 262
ROCHE HOLDING LTD.4.56%220 102
PFIZER9.45%211 109
MERCK AND COMPANY12.38%179 869